EZH2 Inhibition in Mesothelioma Cells Increases the Release of Extracellular Vesicles That Skew Neutrophils Toward a Protumor Phenotype
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110328 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Giulia Pinton und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), 28100 Novara, Italy. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Extracellular Vesicles, Neutrophils, Mesothelioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bando Ricerca UPO 2022 (MUR-DM 737/2021 of PNR and Compagnia San Paolo), Bando Fondazione Oncologica Valdostana 2024, 2022CBYF9P - CUP: C53D23004690001, which has received funding from NextGeneration EU - MUR M4C2- PRIN 2022.
Abstract (Originalsprache)
We previously demonstrated that in BAP1-proficient pleural mesothelioma cells, CDKN2A is critical for mediating the response to selective EZH2 inhibition and highlighted a complex interplay between epigenetic regulation and the tumor immune microenvironment. In this study, we employed a quantitative proteomic mass spectrometry approach to assess alterations in protein expression following EZH2 inhibition in BAP1- and CDKN2A-proficient mesothelioma cells cultured as spheroids. Additionally, we analyzed extracellular vesicles (EVs), which were isolated through tangential flow filtration. Flow cytometric analysis and co-culture systems were used to characterize the effects of EVs on neutrophils. Upon EZH2 inhibition, we demonstrated RAB27b and CD63 upregulation and increased release of extracellular vesicles. We found that a brief exposure to EVs derived from EZH2 inhibitor-treated cells skewed naïve neutrophils toward a pro-tumor phenotype characterized by high levels of PD-L1 and MSLN (Mesothelin) expression on the surface. These EV-elicited neutrophils suppressed T cell proliferation while enhancing tumor cell growth. Moreover, we observed changes in the EV cargo derived from EZH2 inhibitor-treated spheroids. Our findings highlight the significant role of EVs in creating an immunosuppressive microenvironment, and underscore the urgent need for further investigation into the regulation of neutrophil biology and function in the PM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), 28100 Novara, Italy.
- Department of Translational Medicine, University of Piemonte Orientale (UPO), 28100 Novara, Italy.
ORCID-Profile: Elia Bari, Silvia Fallarini, Fausto Chiazza, Maria Luisa Torre, Marcello Manfredi
Förderung
- Bando Ricerca UPO 2022 (MUR-DM 737/2021 of PNR and Compagnia San Paolo)
- Bando Fondazione Oncologica Valdostana 2024
- 2022CBYF9P - CUP: C53D23004690001, which has received funding from NextGeneration EU - MUR M4C2- PRIN 2022
Zitieren
APA
Pinton, G., Bari, E., Fallarini, S., Gigliotti, V., De Giorgis, V., Chiazza, F., Torre, M. L., Manfredi, M., & Moro, L. (2025). EZH2 Inhibition in Mesothelioma Cells Increases the Release of Extracellular Vesicles That Skew Neutrophils Toward a Protumor Phenotype. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110328
Vancouver
Pinton G, Bari E, Fallarini S, Gigliotti V, De Giorgis V, Chiazza F, et al. EZH2 Inhibition in Mesothelioma Cells Increases the Release of Extracellular Vesicles That Skew Neutrophils Toward a Protumor Phenotype. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110328
BibTeX
@article{Pinton2025,
author = {Pinton, Giulia and Bari, Elia and Fallarini, Silvia and Gigliotti, Valentina and De Giorgis, Veronica and Chiazza, Fausto and Torre, Maria Luisa and Manfredi, Marcello and Moro, Laura},
title = {EZH2 Inhibition in Mesothelioma Cells Increases the Release of Extracellular Vesicles That Skew Neutrophils Toward a Protumor Phenotype},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110328}
}
EUVIMED